TIANJIN chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 9.27
Dividend & Yield0.07S$ (7.54%)
Beta N/A
Market capitalization 2.26B
Operating cash flow 301.76M
ESG Scores unknown

Company description

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and healthcare products primarily in the People's Republic of China. It operates in Chinese Medicine and Western Medicine segments. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals. In addition, it provides logistics, stocks, equipment installation, and medicine processing services; medicine inspection and testing services; and pharmaceutical consultancy services. The company sells its medicinal products under its own brand to the wholesalers; and purchases medicinal products under other brands from distributors and sells these to other wholesalers. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was incorporated in 1992 and is based in Tianjin, the People's Republic of China.

Sector: Healthcare - Industry: Drug Manufacturers—Specialty & Generic

Financial Ratios
Quick Ratio2.01
Working Capital0.19
Return On Equity0.12
Debt To Equity0
Fixed Asset Ratio0.03
Fixed Interest Cover199.87

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 257.17M 332.86M 32.13M 231.08M
Total Cashflows From Investing Activities 381.95M -100.79M 73.77M -311.85M
Net Borrowings -81.95M -223.14M -1.1M -1.42M
Total Cash From Financing Activities -252.14M -370.36M -237.26M -244.7M
Change To Operating Activities 9.75M 9.75M 9.75M 10.15M
Issuance Of Stock 28.3M 28.3M 8.36M
Net Income 561.68M 625.57M 661.7M 769.14M
Change In Cash 479.95M 24.34M 507.93M 295.85M
Effect Of Exchange Rate
Total Cash From Operating Activities 350.14M 495.49M 671.42M 852.4M
Depreciation 76.15M 98.15M 110.85M 113.61M
Change To Account Receivables -160.83M -102.7M -113.81M -42.07M
Other Cashflows From Financing Activities -5.45M -2.16M -11.21M -9.87M
Change To Netincome -149.22M -168.91M -142.87M -186.3M
Capital Expenditures -175.81M -205.61M -189.16M -156.95M

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 100.93M 133.36M 149.2M 161.05M
Income Before Tax 640.63M 743.15M 768.06M 872.81M
Net Income 561.68M 625.57M 661.7M 769.14M
Selling General Administrative 2B 2.19B 1.82B 1.93B
Gross Profit 2.62B 2.92B 2.58B 2.75B
Ebit 443.13M 528.19M 551.04M 587.04M
Operating Income 443.13M 528.19M 551.04M 587.04M
Interest Expense -11.38M -4.89M -6.66k -2.94M
Income Tax Expense 72.84M 107.79M 88.4M 85.93M
Total Revenue 6.36B 6.99B 6.6B 6.91B
Cost Of Revenue 3.74B 4.07B 4.02B 4.16B
Total Other Income ExpenseNet 197.5M 214.96M 217.02M 285.76M
Net Income From Continuing Ops 567.79M 635.36M 679.66M 786.88M
Net Income Applicable To Common Shares 561.68M 625.57M 661.7M 769.14M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 2.05B 2.32B 2.33B 2.55B
Total Stockholder Equity 4.93B 5.39B 5.81B 6.36B
Other Current Liabilities 537.18M 712.96M 551.43M 480.03M
Total Assets 7.11B 7.84B 8.28B 9.07B
Common Stock 768.87M 772.8M 773.64M 773.44M
Other Current Assets 202.77M 208.64M 121.13M 495.77M
Retained Earnings 2.75B 3.21B 3.68B 4.22B
Treasury Stock 81.92M 57.88M -11.6M -1.41M
Cash 1.47B 1.48B 1.99B 2.28B
Total Current Liabilities 1.91B 2.16B 2.16B 2.43B
Other Stockholder Equity 81.92M 86.18M 23.19M 30.62M
Property, Plant, and Equipment 1.2B 1.37B 1.46B 1.49B
Total Current Assets 4.78B 5.13B 5.6B 6.42B
Net Tangible Assets 4.75B 5.21B 5.61B 6.17B
Net Receivables 1.73B 1.81B 2.01B 2.01B
Accounts Payable 594.81M 652.64M 902.25M 1.24B


Insider Transactions

Here are the insider transactions of stock shares related to TIANJIN:

Filer Name Transaction Text Ownership Date Filer Relation Shares
NO DATA

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to TIANJIN. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on TIANJIN

Here is the result of two systematic investment strategies applied to TIANJIN. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on TIANJIN

The following chart shows the equity curve of the two systematic investment strategies applied to TIANJIN:

TIANJIN automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 14.73% on the backtest period.

Performance at glance

Performance

14.73 %

Latent gain

294.57 S$

Invested capital

2000.43 S$

Annualized return

3.54 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on TIANJIN

This is the result of two momentum investment strategies applied to TIANJIN. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on TIANJIN

The following chart shows all the entries opened by the momentum investment system on TIANJIN:

TIANJIN momentum entries
  • The first momentum investment strategy would give 21.81% of return on TIANJIN. That represents 654.6S$ of latent gain with 3001.09S$ of employed capital.
  • The second momentum investment strategy would give 18.43% of return on TIANJIN. That represents 599.1S$ of latent gain with 3250.38S$ of employed capital.
Performance at glance (1Q Momentum)

Performance

21.81 %

Latent gain

654.6 S$

Invested capital

3001.09 S$

Annualized return

16.67 %
Performance at glance (2Q Momentum)

Performance

18.43 %

Latent gain

599.1 S$

Invested capital

3250.38 S$

Annualized return

5.01 %

Momentum equity curve on TIANJIN

The following chart shows the equity curve of the two momentum strategies applied to TIANJIN:

TIANJIN momentum equity

Note: the dividends potentially given by TIANJIN are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on TIANJIN

The following chart shows the employed capital evolution of the two momentum strategies on TIANJIN since the beginning:

TIANJIN

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250S$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000S$.


Buy the dip strategy result on TIANJIN

Buy the dip entry openings on TIANJIN

TIANJIN

The performance achieved by the robo-advisor on TIANJIN is 36.0%. That represents 89.91$ of latent gain with 249.75S$ of employed capital. The following chart shows TIANJIN stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of TIANJIN, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

36.0 %

Latent gain

89.91 S$

Invested capital

249.75 S$

Annualized return

16.67 %

Equity curve of the strategy applied to TIANJIN

The following chart shows the result of the investment strategy applied to TIANJIN:

TIANJIN

Note: the dividends potentially given by TIANJIN are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on TIANJIN

The following chart shows the employed capital evolution since the beginning of the investment strategy on TIANJIN:

TIANJIN

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on TIANJIN

In this section, I will compare the three previous investment strategies applied to TIANJIN.

Equity curve comparison on TIANJIN

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

TIANJIN investment strategy comparison

Employed capital comparison on TIANJIN

TIANJIN investment comparison

Performance comparison on TIANJIN

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 14.73% 294.57S$ 2000.43S$ 3.54%
Momentum 1 quarter 21.81% 654.6S$ 3001.09S$ 5.56%
Momentum 2 quarters 18.43% 599.1S$ 3250.38S$ 5.01%
Non-directional 36.0% 89.91S$ 249.75S$ 16.67%
Annualized return comparison

Automatic investment

3.54 %

Momentum 1Q

5.01 %

Momentum 2Q

5.01 %

Non-directional

16.67 %

Correlated stocks

Here are the most positively and negatively correlated stocks with TIANJIN:

Positive correlations

Most correlated stocks this year

  • TIANJIN

  • Most correlated stocks last 3 months

  • Genetic Technologies Ltd
  • TIANJIN
  • BIC
  • DATANG RENEW

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months


    Note: The algorithm computes the probability of correlation between TIANJIN and the other stocks. There may be false positives or some missing correlated stocks. If the price of TIANJIN does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name TIANJIN
    Country China
    City Tianjin
    Address Zhong Xin Mansion
    Phone 86 22 2702 0892
    Website www.zhongxinp.com
    FullTime employees 4650
    Industry Drug Manufacturers—Specialty & Generic
    Sector Healthcare
    Exchange XSES
    Ticker T14.XSES
    Market www.sgx.com

    TIANJIN ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown